HWM
DGX icon

Hemington Wealth Management’s Quest Diagnostics DGX Stock Holding History

Hemington Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$50K Buy
266
+5
+2% +$887 0.01% 360
2025
Q2 		$46K Sell
261
-9
-3% -$1.56K 0.01% 353
2025
Q1 		$45K Sell
270
-3
-1% -$493 0.01% 342
2024
Q4 		$41K Buy
273
+26
+11% +$4.04K 0.01% 348
2024
Q3 		$38K Buy
+247
New +$36.9K 0.01% 350

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hemington Wealth Management's DGX Position: Q3 2025 in Review

Hemington Wealth Management increased its Quest Diagnostics (DGX) stake by 1.9% in Q3 2025, buying an estimated $887 and bringing the position to 266 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #360.

Hemington Wealth Management first reported a position in DGX in Q3 2024 and has held it in 5 quarters since. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Hemington Wealth Management held 266 shares of Quest Diagnostics worth $50K as of Q3 2025.
  • Hemington Wealth Management bought 5 Quest Diagnostics shares in Q3 2025, an estimated $887.
  • Quest Diagnostics made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #360 holding.
  • Hemington Wealth Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 5 quarters since.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.